Genocea Biosciences (GNCA) Tops Q2 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts GNCA Hot Sheet
Join SI Premium – FREE
Genocea Biosciences (NASDAQ: GNCA) reported Q2 EPS of ($0.43), $0.08 better than the analyst estimate of ($0.51). Revenue for the quarter came in at $115 thousand versus the consensus estimate of $50 thousand.
For earnings history and earnings-related data on Genocea Biosciences (GNCA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Top AI Semiconductor Stocks According to Stifel Analysis
- StoneX Reiterates Buy Rating on Marcus Corp. (MCS)
- New Horizon Aircraft (HOVR) Misses Q1 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
